Preformulation and Formulation during Drug Development
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 9202
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is well known that approximately 50% of drug candidates going to clinical trials fail primarily due to efficacy and safety issues. The rest may drop due to solubility, drug–drug interaction, and stability issues. In this sense, preformulation and formulation are key factors improving the rate of success during drug development by improving the physicochemical properties as well as pharmacokinetic properties. In addition, preformulation and formulation play important roles in developing incrementally modified drugs by manipulating physicochemical properties or pharmacokinetic properties of drugs or applying various drug delivery systems. With advances in pharmaceutical technology, in many cases, those issues are not a problem anymore. However, it is still challenging to modify the properties as desired.
In this Special Issue, recent advances in improving and modifying the properties of drugs by applying the knowledge of preformulation and formulation will be discussed.
Prof. Dr. Eun Hee Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- preformulation
- formulation
- design of experiment
- drug delivery system
- solubility
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
